Rights and permissions
About this article
Cite this article
WHO guidelines of MDR-TB cost effective in Estonia and Russia?. Pharmacoecon. Outcomes News 650, 9 (2012). https://doi.org/10.2165/00151234-201206500-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206500-00029